Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Current Leases (2023 - 2024)

Immunome (IMNM) has disclosed Current Leases for 2 consecutive years, with $63000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Current Leases fell 79.68% year-over-year to $63000.0, compared with a TTM value of $63000.0 through Dec 2024, down 79.68%, and an annual FY2024 reading of $63000.0, down 79.68% over the prior year.
  • Current Leases was $63000.0 for Q4 2024 at Immunome, down from $310000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $310000.0 in Q4 2023 and bottomed at $63000.0 in Q4 2024.